Therapeutic Effects of Traditional Chinese Medicine on Spinal Cord Injury: A Promising Supplementary Treatment in Future

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Zhang, Qian ^a   Yang, Hao ^a   An, Jing ^a   Zhang, Rui ^a   Chen, Bo ^a   Hao, Ding Jun ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRAGALUS ROOT; CURCUMIN; EPIGALLOCATECHIN GALLATE; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GINSENOSIDE; PANAX NOTOGINSENG EXTRACT; PUERARIN; QUERCITRIN; RESVERATROL; SALVIA MILTIORRHIZA EXTRACT; TETRAMETHYLPYRAZINE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BLOOD RHEOLOGY; CHINESE HERB; CHINESE MEDICINE; DATA BASE; DRUG MECHANISM; HUMAN; NERVE STIMULATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SPINAL CORD INJURY; THERAPY EFFECT;

EID: 84971440149     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/8958721     Document Type: Review

References (113)

1. L. H. S. Sekhon and M. G. Fehlings, "Epidemiology, demographics, and pathophysiology of acute spinal cord injury, " Spine, vol. 26, no. 24, pp. S2-S12, 2001.
2. N. A. Silva, N. Sousa, R. L. Reis, and A. J. Salgado, "From basics to clinical: A comprehensive reviewon spinal cord injury, " Progress in Neurobiology, vol. 114, pp. 25-57, 2014.
3. J. P. White and P. Thumbikat, "Acute spinal cord injury, " Surgery, vol. 30, no. 7, pp. 326-332, 2012.
4. B. Suberviola, A. González-Castro, J. Llorca, F. Ortiz-Melón, and E. Miñambres, "Early complications of high-dose methylprednisolone in acute spinal cord injury patients, " Injury, vol. 39, no. 7, pp. 748-752, 2008.
5. C. Zhang, J. Ma, L. Fanet al., "Neuroprotective effects of safranal in a rat model of traumatic injury to the spinal cord by antiapoptotic, anti-inflammatory and edema-attenuating, " Tissue and Cell, vol. 47, no. 3, pp. 291-300, 2015.
6. C. Wang, P. Wang, W. Zeng, and W. Li, "Tetramethylpyrazine improves the recovery of spinal cord injury via Akt/Nrf2/HO-1 pathway, " Bioorganic &Medicinal Chemistry Letters, vol. 26, no. 4, pp. 1287-1291, 2016.
7. J. H. Song, M. Liu, W. L. Lei, J. Lu, D. Q. Wang, and Y. M. Yang, "Effect of extracts from leaves of ginkgo bilobe on hindlimbs locomator after spinal cord injury in rats, " Journal of Xi'an JiaotongUniversity (Medical Sciences), vol. 26, no. 2, pp. 166-168, 2005.
8. T. B. Ng, "Pharmacological activity of sanchi ginseng (Panax notoginseng), " The Journal of Pharmacy and Pharmacology, vol. 58, no. 8, pp. 1007-1019, 2006.
9. H. M. Ye, M. X. Yang, and Y. B. Gao, "Empirical study on Fangjifangqi decoction in treating hemitransected spinal cord injury in rats, " Zhejiang Journal of Integrated Traditional Chinese andWestern Medicine, vol. 18, no. 1, pp. 9-11, 2008.
10. L. Wang and D.-M. Jiang, "Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion injury in rats is linked with inhibition of cyclin-dependent kinase 5, " BMC Complementary and Alternative Medicine, vol. 13, article 309, 2013.
11. A. Chen, H. Wang, J. Zhang et al., "BYHWD rescues axotomized neurons and promotes functional recovery after spinal cord injury in rats, " Journal of Ethnopharmacology, vol. 117, no. 3, pp. 451-456, 2008.
12. L. Wang and D.-M. Jiang, "Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia/reperfusion injury in rats, " Journal of Ethnopharmacology, vol. 124, no. 2, pp. 219-223, 2009.
13. M. J. DeVivo, B. K. Go, and A. B. Jackson, "Overview of the national spinal cord injury statistical center database, " Journal of Spinal Cord Medicine, vol. 25, no. 4, pp. 335-338, 2002.
14. F. M. Bareyre and M. E. Schwab, "Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays, " Trends in Neurosciences, vol. 26, no. 10, pp. 555-563, 2003.
15. M. Toborek, A. Malecki, R. Garrido, M. P. Mattson, B. Hennig, and B. Young, "Arachidonic acid-induced oxidative injury to cultured spinal cord neurons, " Journal of Neurochemistry, vol. 73, no. 2, pp. 684-692, 1999.
16. M. S. Beattie, A. A. Farooqui, and J. C. Bresnahan, "Review of current evidence for apoptosis after spinal cord injury, " Journal of Neurotrauma, vol. 17, no. 10, pp. 915-925, 2000.
17. M. J. Crowe, J. C. Bresnahan, S. L. Shuman, J. N. Masters, and M. S. Beattie, "Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys, " Nature Medicine, vol. 3, no. 1, pp. 73-76, 1997.
18. L. Yang, N. R. Jones, P. C. Blumbergs et al., "Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat, " Journal of Clinical Neuroscience, vol. 12, no. 3, pp. 276-284, 2005.
19. D. J. Donnelly and P. G. Popovich, "Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury, " Experimental Neurology, vol. 209, no. 2, pp. 378-388, 2008.
20. T. Morino, T. Ogata, H. Horiuchi et al., "Delayed neuronal damage related to microglia proliferation after mild spinal cord compression injury, " Neuroscience Research, vol. 46, no. 3, pp. 309-318, 2003.
21. G. Yiu and Z. He, "Glial inhibition of CNS axon regeneration, " Nature Reviews Neuroscience, vol. 7, no. 8, pp. 617-627, 2006.
22. Chinese Pharmacopoeia: Part 1, pp. 264-265, 2015.
23. L. Shen and H.-F. Ji, "The pharmacology of curcumin: is it the degradation products?" Trends in Molecular Medicine, vol. 18, no. 3, pp. 138-144, 2012.
24. B. Cemil, K. Topuz, M. N. Demircan et al., "Curcumin improves early functional results after experimental spinal cord injury, " Acta Neurochirurgica, vol. 152, no. 9, pp. 1583-1590, 2010.
25. M.-S. Lin, Y.-H. Lee, W.-T. Chiu, and K.-S. Hung, "Curcumin provides neuroprotection after spinal cord injury, " Journal of Surgical Research, vol. 166, no. 2, pp. 280-289, 2011.
26. W. Jin, J. Wang, T. Zhu et al., "Anti-inflammatory effects of curcumin in experimental spinal cord injury in rats, " Inflammation Research, vol. 63, no. 5, pp. 381-387, 2014.
27. V. P. Menon and A. R. Sudheer, "Antioxidant and antiinflammatory properties of curcumin, " Advances in Experimental Medicine and Biology, vol. 595, pp. 105-125, 2007.
28. H. Ş. Kavakli, C. Koca, and Ö. Alici, "Antioxidant effects of curcumin in spinal cord injury in rats, " Ulusal Travma ve Acil Cerrahi Dergisi, vol. 17, no. 1, pp. 14-18, 2011.
29. B. Ray, S. Bisht, A. Maitra, A. Maitra, and D. K. Lahiri, "Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc-) in the neuronal cell culture and animal model: implications for Alzheimer's disease, " Journal of Alzheimer's Disease, vol. 23, no. 1, pp. 61-77, 2011.
30. J. K. Alexander and P. G. Popovich, "Neuroinflammation in spinal cord injury: Therapeutic targets for neuroprotection and regeneration, " Progress in Brain Research, vol. 175, pp. 125-137, 2009.
31. M. Bishnoi, K. Chopra, L. Rongzhu, and S. K. Kulkarni, "Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence, " Neurotoxicity Research, vol. 20, no. 3, pp. 215-225, 2011.
32. P. Kumar, Y. E. Choonara, G. Modi, D. Naidoo, and V. Pillay, "Cur(Que)min: A neuroactive permutation of curcumin and quercetin for treating spinal cord injury, " Medical Hypotheses, vol. 82, no. 4, pp. 437-441, 2014.
33. J. A. Baur and D. A. Sinclair, "Therapeutic potential of resveratrol: The in vivo evidence, " Nature Reviews Drug Discovery, vol. 5, no. 6, pp. 493-506, 2006.
34. G. J. Soleas, E. P. Diamandis, and D. M. Goldberg, "Wine as a biological fluid: history, production, and role in disease prevention, " Journal of Clinical Laboratory Analysis, vol. 11, no. 5, pp. 287-313, 1997.
35. E.-J. Park and J. M. Pezzuto, "Thepharmacology of resveratrol in animals and humans, " Biochimica et Biophysica Acta, vol. 1852, no. 6, pp. 1071-1113, 2015.
36. O. Ates, S. Cayli, E. Altinoz et al., "Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury, " Acta Pharmacologica Sinica, vol. 27, no. 10, pp. 1317-1325, 2006.
37. Y.-B. Yang and Y.-J. Piao, "Effects of resveratrol on secondary damages after acute spinal cord injury in rats, " Acta Pharmacologica Sinica, vol. 24, no. 7, pp. 703-710, 2003.
38. C. J. Liu, Z. B. Shi, L. H. Fan, C. Zhang, K. Z. Wang, and B. Wang, "Resveratrol improves neuron protection and functional recovery in ratmodel of spinal cord injury, " Brain Research, vol. 1374, pp. 100-109, 2011.
39. U. Kiziltepe, N. N. D. Turan, U. Han, A. T. Ulus, and F. Akar, "Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury, " Journal of Vascular Surgery, vol. 40, no. 1, pp. 138-145, 2004.
40. S. Kaplan, G. Bisleri, J. A. Morgan, F. H. Cheema, and M. C. Oz, "Resveratrol, a natural red wine polyphenol, reduces ischemiareperfusion-induced spinal cord injury, " Annals of Thoracic Surgery, vol. 80, no. 6, pp. 2242-2249, 2005.
41. X.-M. Zhou, M.-L. Zhou, X.-S. Zhang et al., "Resveratrol prevents neuronal apoptosis in an early brain injury model, " Journal of Surgical Research, vol. 189, no. 1, pp. 159-165, 2014.
42. F. Zhang, J. Liu, and J.-S. Shi, "Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation, " European Journal of Pharmacology, vol. 636, no. 1-3, pp. 1-7, 2010.
43. D. G. Nagle, D. Ferreira, and Y.-D. Zhou, "Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives, " Phytochemistry, vol. 67, no. 17, pp. 1849-1855, 2006.
44. E. G. de Mejia, M. V. Ramirez-Mares, and S. Puangpraphant, "Bioactive components of tea: cancer, inflammation and behavior, " Brain, Behavior, and Immunity, vol. 23, no. 6, pp. 721-731, 2009.
45. I. Paterniti, T. Genovese, C. Crisafulli et al., "Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma, " Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 380, no. 2, pp. 179-192, 2009.
46. X. G. Han, W. Tian, and B. Liu, "The therapeutic effect of epigallocatechin gallate on the neurological recovery after spinal cord injury in rat, " Chinese Journal of Spine and Spinal Cord, vol. 23, no. 11, pp. 998-1005, 2013.
47. W. M. Renno, G. Al-Khaledi, A. Mousa, S. M. Karam, H. Abul, and S. Asfar, "(-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats, " Neuropharmacology, vol. 77, pp. 100-119, 2014.
48. F. Deng, R. Li, Y. Yang, D. Zhou, Q. Wang, and J. Xu, "Neuroprotective effect of epigallocatechin-3-gallate on hemisectioninduced spinal cord injury in rats, " Neural Regeneration Research, vol. 6, no. 6, pp. 405-411, 2011.
49. A. R. Khalatbary andH. Ahmadvand, "Anti-inflammatory effect of the epigallocatechin gallate following spinal cord trauma in rat, " Iranian Biomedical Journal, vol. 15, no. 1-2, pp. 31-37, 2011.
50. R. Ge, Y. Zhu, Y. Diao, L. Tao, W. Yuan, and X.-C. Xiong, "Antiedema effect of epigallocatechin gallate on spinal cord injury in rats, " Brain Research, vol. 1527, pp. 40-46, 2013.
51. Y. Q. Jin, Y. L. Hong, J. R. Li, X. Li, X. X. Wang, and L. G. Hua, "Advancements in the chemical constituents and pharmacological effects of Chuanxiong, " Pharmacy and Clinics of Chinese Materia Medica, vol. 4, no. 3, pp. 44-48, 2013.
52. Z. Zhang, T. Wei, J. Hou, G. Li, S. Yu, and W. Xin, "Tetramethylpyrazine scavenges superoxide anion and decreases nitric oxide production in human polymorphonuclear leukocytes, " Life Sciences, vol. 72, no. 22, pp. 2465-2472, 2003.
53. C.-C. Wu, W.-F. Chiou, and M.-H. Yen, "A possible mechanism of action of tetramethylpyrazine on vascular smooth muscle in rat aorta, " European Journal of Pharmacology, vol. 169, no. 2-3, pp. 189-195, 1989.
54. L. Fan, K. Wang, Z. Shi, J. Die, C. Wang, and X. Dang, "Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury, " Journal of Vascular Surgery, vol. 54, no. 1, pp. 192-200, 2011.
55. L.-H. Fan, K.-Z. Wang, B. Cheng, C.-S. Wang, and X.-Q. Dang, "Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following spinal cord ischemia in rabbits, " BMC Neuroscience, vol. 7, pp. 48-56, 2006.
56. Y.-H. Shih, S.-L. Wu, W.-F. Chiou, H.-H. Ku, T.-L. Ko, and Y.-S. Fu, "Protective effects of tetramethylpyrazine on kainateinduced excitotoxicity in hippocampal culture, " NeuroReport, vol. 13, no. 4, pp. 515-519, 2002.
57. L. Lv, S.-S. Jiang, J. Xu, J.-B. Gong, and Y. Cheng, "Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: The role of endothelial nitric oxide synthase, " Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 1, pp. 20-27, 2012.
58. X. Xiao, Y. Liu, C. Qi et al., "Neuroprotection and enhanced neurogenesis by tetramethylpyrazine in adult rat brain after focal ischemia, " Neurological Research, vol. 32, no. 5, pp. 547-555, 2010.
59. M. Russo, C. Spagnuolo, I. Tedesco, S. Bilotto, and G. L. Russo, "The flavonoid quercetin in disease prevention and therapy: facts and fancies, " Biochemical Pharmacology, vol. 83, no. 1, pp. 6-15, 2012.
60. Nutrient Data Laboratory, Food Composition Laboratory, Beltsville Human Nutrition Research Center, and Agricultural Research Service, USDA Database for the Flavonoid Content of Selected Foods, U. S. Department of Agriculture, Baltimore, Md, USA, 2007, http://www. Ars. usda. gov/nutrientdata.
61. M. Harwood, B. Danielewska-Nikiel, J. F. Borzelleca, G. W. Flamm, G. M. Williams, and T. C. Lines, "A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties, " Food and Chemical Toxicology, vol. 45, no. 11, pp. 2179-2205, 2007.
62. Y. Song, J. Liu, F. Zhang, J. Zhang, T. Shi, and Z. Zeng, "Antioxidant effect of quercetin against acute spinal cord injury in rats and its correlation with the p38MAPK/iNOS signaling pathway, " Life Sciences, vol. 92, no. 24-26, pp. 1215-1221, 2013.
63. Ö. Çevik, M. Er Şahin, T. E. Şener et al., "Beneficial effects of quercetin on rat urinary bladder after spinal cord injury, " Journal of Surgical Research, vol. 183, no. 2, pp. 695-703, 2013.
64. S.-Y. Wei, Y. Chen, and X.-Y. Xu, "Progress on the pharmacological research of puerarin: A review, " Chinese Journal of Natural Medicines, vol. 12, no. 6, pp. 407-414, 2014.
65. F. Tian, L.-H. Xu, W. Zhao, L.-J. Tian, and X.-L. Ji, "The optimal therapeutic timing and mechanism of puerarin treatment of spinal cord ischemia-reperfusion injury in rats, " Journal of Ethnopharmacology, vol. 134, no. 3, pp. 892-896, 2011.
66. F. Tian, L.-H. Xu, B. Wang, L.-J. Tian, and X.-L. Ji, "The neuroprotective mechanism of puerarin in the treatment of acute spinal ischemia-reperfusion injury is linked to cyclindependent kinase 5, " Neuroscience Letters, vol. 584, pp. 50-55, 2015.
67. F. Tian, L.-H. Xu, W. Zhao, L.-J. Tian, and X.-L. Ji, "The neuroprotective mechanism of puerarin treatment of acute spinal cord injury in rats, " Neuroscience Letters, vol. 543, pp. 64-68, 2013.
68. L.-Q. Shan, S. Ma, X.-C. Qiu et al., "Hydroxysafflor yellow A protects spinal cords from ischemia/reperfusion injury in rabbits, " BMC Neuroscience, vol. 11, article 98, 2010.
69. L. Wang and X. Tian, "Effects of Tetrandrine on the nerve cells' apoptosis and the expression of Bcl-2 and Bax after spinal cord injury, " Bone, vol. 44, supplement 1, pp. S116-S117, 2009.
70. Z.-H. Zhao, Experimental study on neuroprotective effect and mechanism of piperine for spinal cord injury in rats [Master of Medicine thesis], Hebei Medical University, 2012.
71. Y.-G. Li, L. Song, M. Liu, Z. B. Hu, and Z.-T. Wang, "Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen), " Journal of Chromatography A, vol. 1216, no. 11, pp. 1941-1953, 2009.
72. T. O. Cheng, "Danshen: A versatile Chinese herbal drug for the treatment of coronary heart disease, " International Journal of Cardiology, vol. 113, no. 3, pp. 437-438, 2006.
73. L. Zhou, Z. Zuo, and M. S. S. Chow, "Danshen: Anoverviewof its chemistry, pharmacology, pharmacokinetics, and clinical use, " Journal of Clinical Pharmacology, vol. 45, no. 12, pp. 1345-1359, 2005.
74. L. Wei, Effect of Salvia miltiorrhiza on motor function in gray matter of acute spinal cord injury in rat and its mechanism [Doctor of Medicine thesis] , Fujian University of Traditional Chinese Medicine, 2013.
75. G. Wang, S. Liu, W. Zheng, and Y. Hu, "Effect of Danshen on spinal cord blood flow and hemorrheological indexes after spinal cord injury in rabbits, " Chinese Journal of Microcirculation, vol. 13, no. 4, pp. 11-12, 2003.
76. D. Q. Guo, L. Yang, D. P. Wang, X. Chen, H. Guan, and J. D. Xiao, "Experimental study on how Salvia miltiorrhiza works on changes of free radical at early stage of spinal cord injury, " Journal of ChineseMicrocirculation, vol. 9, no. 1, pp. 38-40, 2005.
77. J. Wang, K. Kong, W. Qi et al., "Effects of Salvia miltiorrhiza on nuclear factor-B activity in rats with acute traumatic spinal cord injury, " Chinese Journal of Bone and Joint Injury, vol. 22, no. 4, pp. 307-309, 2007.
78. L. Wang and Y. H. Liu, "Effects of Salvia Miltiorrhiza on the myelin basic protein after the spinal cord injury of rats, " Chinese Archives of Traditional ChineseMedicine, vol. 24, no. 8, pp. 1537-1539, 2006.
79. EuropeanMedicines Agency and Committee onHerbalMedicinal Products, "Assessment report on Ginkgo biloba L., folium, " Tech. Rep., European Medicines Agency, London, UK, 2014, http://www. ema. europa. eu/ema/.
80. T. Heinonen and W. Gaus, "Cross matching observations on toxicological and clinical data for the assessment of tolerability and safety of Ginkgo biloba leaf extract, " Toxicology, vol. 327, pp. 95-115, 2015.
81. T. A. van Beek, "Chemical analysis of Ginkgo biloba leaves and extracts, " Journal of Chromatography A, vol. 967, no. 1, pp. 21-55, 2002.
82. H. Herrschaft, A. Nacu, S. Likhachev, I. Sholomov, R. Hoerr, and S. Schlaefke, "Ginkgo biloba extract EGb 7615 in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg, " Journal of Psychiatric Research, vol. 46, no. 6, pp. 716-723, 2012.
83. H. J. Song, M. Liu, W. L. Lei, J. Lu, D. Q. Wang, and Y. M. Yang, "Effect of extracts from leaves of ginkgo bilobe on hindlimbs locomator after spinal cord injury in rats, " Journal of Xi'an JiaotongUniversity (Medical Sciences), vol. 26, no. 2, pp. 166-168, 2005.
84. F. Zhang, W. W. Feng, and H. T. Zhou, "The function of the extracts of Ginkgo biloba on rats spinal cord injury and its mechanism, " Chinese Journal of Spine and Spinal Cord, vol. 17, no. 9, pp. 675-679, 2007.
85. J. F. Jiang, F. Zhang, and A. C. Wei, "Experimental study on neuroprotective effect of EGb after spinal cord injury in rats, " Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 21, no. 18, pp. 1958-1960, 2012.
86. R. K. Koç, H. Akdemir, A. Kurtsoy et al., "Lipid peroxidation in experimental spinal cord injury, " Research in Experimental Medicine, vol. 195, no. 1, pp. 117-123, 1995.
87. J. J. Jiao, J. N. Jiang, B. Du, Y. Mo, M. Zhou, and H. Q. Zhang, "Effect of Ginkgo biloba extract EGb761 on healing of nerve injury after spinal cord injury in rats, " Journal of Clinical Medicine in Practice, vol. 14, no. 15, pp. 5-8, 2010.
88. J. J. Jiao, J. N. Jiang, B. Du, Y. Mo, M. Zhou, and H. Q. Zhang, "Neuro-protective effect of Ginkgo biloba extract EGb761 on spinal cord injury in rats, " Anhui Medical and Pharmaceutical Journal, vol. 14, no. 10, pp. 1138-1140, 2010.
89. B. Cheng, W. Wang, L. Lin, F. Li, and X. Wang, "The change of the spinal cord ischemia-reperfusion injury in mitochondrial passway and the effect of the Ginkgo biloba extract's preconditioning intervention, " Cellular andMolecular Neurobiology, vol. 31, no. 3, pp. 415-420, 2011.
90. X. S. Wang, R. S. Xu, Y. W. Sun, J. Xue, and J. S. Wu, "Effect of ginkgolide A on the repairing of nerve fibers after acute spinal cord injury in rats, " Jiangsu Medical Journal, vol. 39, no. 19, pp. 2236-2238, 2013.
91. Y. Song, Z. Zeng, C. Jin, J. Zhang, B. Ding, and F. Zhang, "Protective effect of ginkgolide B against acute spinal cord injury in rats and its correlation with the JAK/STAT signaling pathway, " Neurochemical Research, vol. 38, no. 3, pp. 610-619, 2013.
92. H. Yu, Study of the ginkgolide B improve motor capaeity and inhabit apoptosis after spinal cord injury in rats [M. S. Thesis], 2006.
93. M. Li, The effect of ginkgolides B on glial cells after spinal cord injury in rats [Master of Medicine], 2006.
94. G. B. Elyakov, L. I. Strigina, N. I. Uvarova, V. E. Vaskovsky, A. K. Dzizenko, and N. K. Kochetkov, "Glycosides from ginseng roots, " Tetrahedron Letters, vol. 5, no. 48, pp. 3591-3597, 1964.
95. C. H. Lee and J.-H. Kim, "A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases, " Journal of Ginseng Research, vol. 38, no. 3, pp. 161-166, 2014.
96. J. C. Liu, F. Yin, G. Zhao, and S. H. Yuan, "Spinal cord injury treated by Gen-seng saponin-an experiment study, " Chinese Journal of Gerontology, vol. 5, pp. 303-305, 2000.
97. J. W. Shang, Effects of ginsenoside on apoptosis of neurons and expressions of Bcl-2 and Caspase-3 in rats with spinal cord injury [Master of Medicine], 2003.
98. B. Liao, H. Newmark, and R. Zhou, "Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro, " Experimental Neurology, vol. 173, no. 2, pp. 224-234, 2002.
99. Y. X. Song, C. Y. Jin, Z. Y. Zeng, B. Wang, and J. Q. Zhang, "Study on the mechanism underlying neuroprotective effect of Ginsenosides in rats after spinal cord injury, " Hainan Medical Journal, vol. 20, no. 5, pp. 6-9, 2009.
100. H. Sun, Z. Yang, and Y. Ye, "Structure and biological activity of protopanaxatriol-type saponins from the roots of Panax notoginseng, " International Immunopharmacology, vol. 6, no. 1, pp. 14-25, 2006.
101. W.-Z. Yang, Y. Hu, W.-Y. Wu, M. Ye, and D.-A. Guo, "Saponins in the genus Panax L. (Araliaceae): A systematic review of their chemical diversity, " Phytochemistry, vol. 106, pp. 7-24, 2014.
102. T. B. Ng, "Pharmacological activity of sanchi ginseng (Panax notoginseng), " Journal of Pharmacy and Pharmacology, vol. 58, no. 8, pp. 1007-1019, 2006.
103. N. Ning, X. Dang, C. Bai, C. Zhang, and K. Wang, "Panax notoginsenoside produces neuroprotective effects in rat model of acute spinal cord ischemia-reperfusion injury, " Journal of Ethnopharmacology, vol. 139, no. 2, pp. 504-512, 2012.
104. H. Li, Z. J. Zhao, D. Pan et al., "Protective effect of TSPN on spinal cord injury and its GFAP relative mechanism, " Progress in Modern Biomedicine, vol. 10, no. 10, pp. 1825-1827, 2010.
105. W.-Q. Yuan, H. Wang, Y.-X. Zhao, and Y.-J. Li, "Effect of panax notoginseng saponin on behavior changes and apoptosis in rats with spinal cord injury, " Chinese Journal of Clinical Rehabilitation, vol. 10, no. 15, pp. 62-64, 2006.
106. C. Chu, L.-W. Qi, E.-H. Liu, B. Li, W. Gao, and P. Li, "Radix astragali (Astragalus): latest advancements and trends in chemistry, analysis, pharmacology and pharmacokinetics, " Current Organic Chemistry, vol. 14, no. 16, pp. 1792-1807, 2010.
107. M. Jin, K. Zhao, Q. Huang, and P. Shang, "Structural features and biological activities of the polysaccharides from Astragalus membranaceus, " International Journal of Biological Macromolecules, vol. 64, pp. 257-266, 2014.
108. J. M. Zhang and K. M. Tang, "Neuroprotective function of astragalus injection on treatment of rats with acute spinal cord injury, " Journal of Clinical Medicine in Practice, vol. 18, no. 24, pp. 7-10, 2014.
109. S. Q. Liu, Y. G. Ma, H. Peng, and A. L. Wei, "Neuroprotective effects of Astragalus root on experimentally spinal cord injury in rats, " China Journal of Orthopaedics and Traumatology, vol. 16, no. 8, pp. 463-465, 2003.
110. X.-S. Ren, X.-Y. Leng, Y.-G. Yang, and X.-X. Xu, "Neuroprotective effect of astragalus root on experimental injury of spinal cord in rats, " Chinese Journal of Clinical Rehabilitation, vol. 10, no. 7, pp. 31-33, 2006.
111. G. F. Zhang and H. M. Wang, "Effect of Buyang-Huanwu decoction for treatment of spinal cord injury by mesenchymal stem cells transplantation in rats, " China Journal of Orthopaedics and Traumatology, vol. 19, no. 8, pp. 452-454, 2006.
112. J. P. Zhang, Z. B. Wang, A. H. Lin, S. G. Li, F. N. Wen, and H. Yao, "Influence of Buyang Huanwu Decoction on the ultrastructure of spinal cord tissue in rats with spinal cord injury, " Traditional Chinese Drug Research & Clinical Pharmacology, vol. 22, no. 2, pp. 153-157, 2011.
113. Y. Liu and Y. C. Miao, "Influence of zibu piyin recipe on expression of brain-derived neurotrophic factor after spinal cord injury in rats, " Journal of Shandong University (Health Sciences), vol. 50, no. 10, pp. 33-36, 2012.